The pairing of Mallinckrodt plc and Endo Inc. is expected to create a pharma heavyweight that will generate $3.6 billion in 2025 revenue after the duo combines their generic pharmaceuticals businesses ...

Mallinckrodt and Endo are merging in a $6.7 billion deal, with a pro forma NYSE listing and $900 million in financing.

Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York Stock Exchange, the two drugmakers said Thursday.

The merger will give the combined entity the financial flexibility to pursue drug licensing deals and broaden its therapeutic ...

More than a decade after earning FDA approval for Xiaflex as a nonsurgical treatment option for Dupuytren’s contracture, Endo is debuting its first-ever branded TV commercial in the indication.

Endometriosis is a condition that can affect females. It happens when tissue that is similar to that of endometrial tissue grows outside the uterus. It can be difficult to diagnose and carries ...

“I’m still happy to be a part of this club and I can still feel like I can do something for this club.” While things will likely change in the summer if the right offer presents itself, Endo ...

Wataru Endo has had to accept a role largely as an ... just keep working hard,” he told LFCTV. “I’m still happy to be a part of this club and I can still feel like I can do something for ...